BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 6481705)

  • 1. Oral contraceptives and neoplasia.
    Stubblefield PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):524-9. PubMed ID: 6481705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic effects of oral contraceptives.
    Grimes DA
    Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancers of the uterus and ovary and the contraceptive pill].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):339-43. PubMed ID: 12280204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
    Grimes DA
    Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and endometrial cancer.
    Cole P
    N Engl J Med; 1980 Mar; 302(10):575-6. PubMed ID: 7351894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pill and cancer--IPPF response.
    IPPF Med Bull; 1983 Dec; 17(6):1-2. PubMed ID: 12279693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and cancer.
    Edgren RA
    Int J Fertil; 1991; 36 Suppl 3():37-50. PubMed ID: 1687403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives.
    Shearman RP
    Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and cancer.
    FDA Drug Bull; 1984 Apr; 14(1):2-3. PubMed ID: 6734989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination oral contraceptives and cancer risk.
    Gast K; Snyder T
    Kans Med; 1990 Jul; 91(7):201-8. PubMed ID: 2202849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and cancer of the reproductive organs.
    Huezo C
    IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCs and genital tract malignancies.
    Herbst AL
    Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term health risks and benefits of oral contraceptive use.
    Peterson HB; Lee NC
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):775-88. PubMed ID: 2092241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.